FDA Weighs Unapproved Peptides

Silver SpringAn FDA panel weighs seven unapproved peptides.

Advisory committees screen members for conflicts of interest, a safeguard added after past drug-approval tragedies, says former adviser Mikkael Sekeres.

Sekeres warns loosening that oversight risks repeating the harms that built it.

Sources: Undark